Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Income from Non-Controlling Interests (2022 - 2024)

Historic Income from Non-Controlling Interests for Jaguar Health (JAGX) over the last 3 years, with Q2 2024 value amounting to -$136000.0.

  • Jaguar Health's Income from Non-Controlling Interests rose 354.61% to -$136000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was -$543000.0, marking a year-over-year increase of 4953.53%. This contributed to the annual value of -$759000.0 for FY2024, which is 2628.95% down from last year.
  • As of Q2 2024, Jaguar Health's Income from Non-Controlling Interests stood at -$136000.0, which was up 354.61% from -$142000.0 recorded in Q1 2024.
  • Over the past 5 years, Jaguar Health's Income from Non-Controlling Interests peaked at -$23000.0 during Q2 2022, and registered a low of -$651000.0 during Q4 2022.
  • Over the past 3 years, Jaguar Health's median Income from Non-Controlling Interests value was -$140000.0 (recorded in 2023), while the average stood at -$182000.0.
  • The largest annual percentage gain for Jaguar Health's Income from Non-Controlling Interests in the last 5 years was 7864.82% (2023), contrasted with its biggest fall of 51304.35% (2023).
  • Over the past 3 years, Jaguar Health's Income from Non-Controlling Interests (Quarter) stood at -$651000.0 in 2022, then soared by 78.65% to -$139000.0 in 2023, then increased by 2.16% to -$136000.0 in 2024.
  • Its last three reported values are -$136000.0 in Q2 2024, -$142000.0 for Q1 2024, and -$139000.0 during Q4 2023.